Commentary on variability in vitamin K antagonist metabolism

Author： Smith Dennis A  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.2, Iss.1, 2006-02, pp. : 1-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contribution of CYP2C9 to variability in vitamin K antagonist metabolism

By Daly Ann K   King Barry P  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Iss. 1, 2006-02 ,pp. : 3-15

Informa Healthcare

Access to resources Recommend Favorite

Vitamin K antagonist: Spinal subdural haematoma in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1247-1248, 2009-01 ,pp. : 34-34

Adis International

Access to resources Recommend Favorite

Careful management can reduce the risk of bleeding in elderly patients receiving vitamin K antagonist (VKA) therapy

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 12, 2006-12 ,pp. : 23-26

Adis International

Access to resources Recommend Favorite

Vitamin K antagonist overdose: Intramural duodenal haematoma in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1219, 2008-01 ,pp. : 35-35

Adis International

Access to resources Recommend Favorite

Effects of Vitamin K2 on Osteoporosis

By  

Current Pharmaceutical Design, Vol. 10, Iss. 21, 2004-08 ,pp. : 2557-2576

Bentham Science Publishers

Access to resources Recommend Favorite